Latest News for: atrophy

Edit

Rep. Mullin Introduces Resolution Recognizing “Multiple System Atrophy Awareness Month” (Kevin Mullin)

Public Technologies 18 Mar 2026
"A constituent whose close friend recently passed away from this debilitating disorder contacted my office wanting to help raise awareness about Multiple System Atrophy.
Edit

IZERVAY Market to Witness Robust Growth Through 2034 Driven by Rising Geographic Atrophy Treatment Adoption, ...

GetNews 18 Mar 2026
IZERVAY (avacincaptad pegol intravitreal solution), a complement C5 inhibitor, has rapidly emerged as a transformative therapy in the treatment landscape of Geographic Atrophy (GA) secondary to age-related macular degeneration (AMD).
Edit

ISS study identifies thresholds for muscle atrophy and fiber changes in reduced gravity

Phys Dot Org 16 Mar 2026
It's well known that spaceflight causes muscle atrophy and other biological changes in reduced gravity, and especially in near-zero gravity (microgravity) environments ... Without this gravitational force acting on our bodies, muscles begin to atrophy.
Edit

ONL Therapeutics Announces First European Patient Randomized in its Global Phase 2 GALAXY Trial of Xelafaslatide (ONL1204) in Patients with Geographic Atrophy (GA) Associated with Dry AMD

PR Newswire 16 Mar 2026
GALAXY is a global Phase 2 clinical trial designed to evaluate the efficacy and safety of xelafaslatide (formerly ONL1204) in patients with geographic atrophy (GA) associated with dry age-related macular degeneration (AMD).
Edit

VA Research Wrap Up: New findings on brain health, cardiovascular disease and muscle atrophy (US Department of Veterans Affairs)

Public Technologies 13 Mar 2026
... a potential way to protect the blood-brain barrier, a lifestyle coaching app for cardiovascular disease and preventing muscle atrophy.
Edit

Alterity Therapeutics Recognizes Multiple System Atrophy (MSA) Awareness Month in March and the

Caledonian Record 02 Mar 2026
– Company is advancing ATH434 in late-stage clinical development for Multiple System Atrophy, a rapidly progressive neurodegenerative disease with no approved therapies – ....
Edit

Alterity Therapeutics Recognizes Multiple System Atrophy (MSA) Awareness Month in March and the Urgent Need ...

Nasdaq Globe Newswire 02 Mar 2026
– Company is advancing ATH434 in late-stage clinical development for Multiple System Atrophy, a rapidly progressive neurodegenerative disease with no approved therapies – ... .
Edit

Are we designing for efficiency or cognitive atrophy (Telefónica SA)

Public Technologies 26 Feb 2026
) The widespread introduction of AI has pushed us to interact on autopilot. quick responses, effortless and often without real understanding ... [...]. This is an abstract of the document.
Edit

GEMMABio Announces First Patient Dosed in CHARISMA Trial of GB221, Investigational Next‑Generation Gene Therapy for Spinal Muscular Atrophy Type 1 (SMA1)

PR Newswire 26 Feb 2026
About SMA1 Spinal muscular atrophy (SMA) is a progressive neurodegenerative disease that affects motor neurons in the spinal cord and adversely affects the skeletal muscles.  Progressive muscle ...
Edit

Navigating recruitment complexity and regional nuances in a Phase III Global Geographic Atrophy trial (Fortrea Holdings Inc)

Public Technologies 25 Feb 2026
) CASE STUDY Navigating recruitment complexity and regional nuances in a Phase III Global Geographic Atrophy trial A KEY QUESTION When patient recruitment ...
Edit

Ace Therapeutics Unveils Customized NHP Models for Geographic Atrophy Drug Development to Accelerate AMD Therapeutic Research

GetNews 18 Feb 2026
Ace Therapeutics announced the launch of its validated and customized non-human primate (NHP) models designed for the preclinical study of geographic atrophy (GA) ... Geographic atrophy is an advanced AMD ...
Edit

Feeling free in water: 10-year-old boy with spinal muscular atrophy learns to defy physical limits

Straits Times 15 Feb 2026
The water offers something rare - independence and a chance to move freely - for the Primary 5 boy ....
Edit

Stoke Therapeutics Announces First Patient Dosed in Phase 1 Study of STK-002, a Potential Disease-Modifying Medicine for the Treatment of Autosomal Dominant Optic Atrophy (ADOA)

Pharmiweb 11 Feb 2026
... patient has been dosed in the Phase 1 OSPREY study of STK-002, an investigational medicine for the treatment of Autosomal Dominant Optic Atrophy (ADOA) ... About Autosomal Dominant Optic Atrophy (ADOA).
Edit

Fertility Authority Flags Genetic Threat in European Donor Sperm

Greek City Times 08 Feb 2026
... screening requirements for spinal muscular atrophy (SMA) in donor sperm.
Edit

ZipBio and MeiraGTx Enter into Exclusive License Agreement to Advance First-in-Class AAV Gene Therapy for Geographic Atrophy

PR Newswire 03 Feb 2026
Under the agreement, MeiraGTx will receive exclusive rights to ZipBio's first-in-class therapies for Geographic Atrophy, targeting the complement pathway.

Article Search

tools
×
×
×
×